Together with the Innovation and Investment Fund Gelderland, the Zeeland Investment Fund invests in Soteria Medical BV. Soteria has developed a robotic arm that is used for prostate biopsies in an MRI environment. Soteria Medical completed the clinical trials in 2013 and will bring the robot arm on market in 2014.
Prostate cancer is the most common form of cancer among men. As many as 1 out of 7 men will face prostate cancer. Increasingly, MRI is used to better analyze the development of aggressive tumors in the prostate and for taking a biopsy.
One of the world’s leading centers in the field of detection and treatment of prostate cancer is the St. Radboud University Medical Center in Nijmegen. Patients from all over the Netherlands and around the world visit the St. Radboud because they apply the latest techniques. St. Radboud has developed a number of these techniques.
One of these newly developed techniques is a robot that is able to automatically move the biopsy needle to a suspicious spot on the prostate, while the patient lies in the MRI. This procedure is performed faster and more accurately than other biopsy methods, resulting in an improved diagnosis and a more patient-friendly and cost-efficient treatment. The knowledge and unique technology of the St. Radboud is housed at Soteria.
“Soteria Medical is excited to be working with ZIF and IIG, who will help us proceed with the clinical testing of our Remote Controlled Manipulator (RCM) at St. Radboud, and to finalize the product design for the planned market launch later in 2014,” says CEO Jan Sabisch.
More information about Soteria Medical.
Prostate cancer is the most common form of cancer among men. As many as 1 out of 7 men will face prostate cancer. Increasingly, MRI is used to better analyze the development of aggressive tumors in the prostate and for taking a biopsy.
One of the world’s leading centers in the field of detection and treatment of prostate cancer is the St. Radboud University Medical Center in Nijmegen. Patients from all over the Netherlands and around the world visit the St. Radboud because they apply the latest techniques. St. Radboud has developed a number of these techniques.
One of these newly developed techniques is a robot that is able to automatically move the biopsy needle to a suspicious spot on the prostate, while the patient lies in the MRI. This procedure is performed faster and more accurately than other biopsy methods, resulting in an improved diagnosis and a more patient-friendly and cost-efficient treatment. The knowledge and unique technology of the St. Radboud is housed at Soteria.
“Soteria Medical is excited to be working with ZIF and IIG, who will help us proceed with the clinical testing of our Remote Controlled Manipulator (RCM) at St. Radboud, and to finalize the product design for the planned market launch later in 2014,” says CEO Jan Sabisch.
More information about Soteria Medical.